SARS-CoV-2 also upregulates glycolysis in host immune cells via HIF1α, as evidenced by elevated pyruvate, pyruvate kinase, and lactate dehydrogenase (LDH) in COVID-19 patients (86). Here, HIF1A is linked to COVID-19.